Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
Frequently asked questions
What sector does Pharmagreen Biotech Inc (PHBI) operate in?
Pharmagreen Biotech Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Pharmagreen Biotech Inc (PHBI) current stock price?
As of the latest data, Pharmagreen Biotech Inc stock price is $0.14, with a previous close of $0.14.
What is Pharmagreen Biotech Inc (PHBI) current market capitalization?
Pharmagreen Biotech Inc market cap is approximately 93.95 million.
Does Pharmagreen Biotech Inc (PHBI) pay dividends?
No. Pharmagreen Biotech Inc does not pay a dividend.
What is Pharmagreen Biotech Inc (PHBI) beta (volatility) score?
Pharmagreen Biotech Inc has a beta of 1.743, suggesting it is more volatile than the market.